AIM
IONS icon

ARK Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$35.6M Sell
900,318
-100,209
-10% -$3.96M 0.26% 58
2025
Q1
$30.2M Sell
1,000,527
-24,733
-2% -$746K 0.3% 50
2024
Q4
$35.8M Sell
1,025,260
-359,009
-26% -$12.6M 0.3% 52
2024
Q3
$55.5M Buy
1,384,269
+23,244
+2% +$931K 0.51% 38
2024
Q2
$64.9M Sell
1,361,025
-38,827
-3% -$1.85M 0.58% 33
2024
Q1
$60.7M Sell
1,399,852
-505,204
-27% -$21.9M 0.42% 41
2023
Q4
$96.4M Sell
1,905,056
-461,311
-19% -$23.3M 0.57% 34
2023
Q3
$107M Sell
2,366,367
-56,264
-2% -$2.55M 0.82% 28
2023
Q2
$99.4M Sell
2,422,631
-214,561
-8% -$8.8M 0.66% 31
2023
Q1
$94.3M Sell
2,637,192
-36,346
-1% -$1.3M 0.65% 29
2022
Q4
$101M Sell
2,673,538
-1,039,569
-28% -$39.3M 0.88% 24
2022
Q3
$164M Sell
3,713,107
-988,190
-21% -$43.7M 1.14% 24
2022
Q2
$172M Sell
4,701,297
-1,470,011
-24% -$53.7M 1.02% 25
2022
Q1
$229M Sell
6,171,308
-911,948
-13% -$33.8M 0.95% 28
2021
Q4
$216M Sell
7,083,256
-1,428,128
-17% -$43.5M 0.65% 34
2021
Q3
$285M Sell
8,511,384
-396,349
-4% -$13.3M 0.69% 37
2021
Q2
$355M Buy
8,907,733
+3,765,462
+73% +$150M 0.66% 43
2021
Q1
$231M Buy
5,142,271
+2,742,717
+114% +$123M 0.46% 59
2020
Q4
$136M Buy
2,399,554
+1,896,994
+377% +$107M 0.36% 63
2020
Q3
$23.8M Buy
502,560
+158,429
+46% +$7.52M 0.14% 81
2020
Q2
$20.3M Buy
344,131
+224,450
+188% +$13.2M 0.22% 61
2020
Q1
$5.66M Sell
119,681
-96,344
-45% -$4.56M 0.14% 74
2019
Q4
$13.1M Buy
216,025
+19,356
+10% +$1.17M 0.33% 48
2019
Q3
$11.8M Buy
196,669
+38,896
+25% +$2.33M 0.26% 55
2019
Q2
$10.1M Sell
157,773
-7,205
-4% -$463K 0.26% 53
2019
Q1
$13.4M Sell
164,978
-77,334
-32% -$6.28M 0.38% 44
2018
Q4
$13.1M Buy
242,312
+12,994
+6% +$702K 0.53% 38
2018
Q3
$11.8M Buy
229,318
+16,191
+8% +$835K 0.36% 53
2018
Q2
$8.88M Sell
213,127
-138,778
-39% -$5.78M 0.33% 56
2018
Q1
$15.5M Sell
351,905
-18,930
-5% -$834K 0.77% 44
2017
Q4
$18.7M Buy
370,835
+123,372
+50% +$6.21M 1.49% 29
2017
Q3
$12.5M Buy
247,463
+70,472
+40% +$3.57M 1.53% 26
2017
Q2
$9M Buy
176,991
+49,428
+39% +$2.51M 1.75% 23
2017
Q1
$5.13M Buy
127,563
+120,942
+1,827% +$4.86M 1.48% 28
2016
Q4
$317K Buy
+6,621
New +$317K 0.12% 69